Literature DB >> 19898283

Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state.

Prakash C Deedwania1, Enrique V Carbajal.   

Abstract

The primary objective of treatment in patients with chronic coronary artery disease (CAD) and stable angina is relief of symptoms and improvement of clinical outcome. The American College of Cardiology/American Heart Association guidelines have emphasized the role of evidence-based therapies. There have been regular updates of the guidelines, with an effort to include the latest data in the recommendations. Since the 2002 guidelines were published, there have been several pivotal studies that have provided strong support for the role of aggressive and optimal medical therapy in improving clinical outcomes in patients with chronic CAD. Recent data from 2 landmark studies have emphasized that optimal medical therapy is as effective as myocardial revascularization with percutaneous coronary intervention or coronary artery bypass grafting in reducing risk of adverse clinical outcomes. The 2009-2010 guidelines will likely incorporate the findings of these studies and accordingly modify the recommendations for treatment of patients with chronic CAD and stable angina.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898283     DOI: 10.3909/ricm10S10003

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  1 in total

1.  Effect of Shenzhu Guanxin Recipe () on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial.

Authors:  Dan-Ping Xu; Huan-Lin Wu; Tao-Hua Lan; Xia Wang; Xiao-Gang Sheng; Yu Lin; Song Li; Chao-Yang Zheng
Journal:  Chin J Integr Med       Date:  2015-06-11       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.